Group One Trading
TNXP icon

Group One Trading’s Tonix Pharmaceuticals TNXP Stock Holding History

Group One Trading’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.4K Sell
760
-900
-54% -$13.9K ﹤0.01% 6352
2025
Q4 		$25.9K Buy
1,660
+1,237
+292% +$22.8K ﹤0.01% 6154
2025
Q3 		$10.2K Buy
+423
New +$15.7K ﹤0.01% 7150
2019
Q2 		– Hold
0
– – – 5393
2019
Q1 		– Hold
0
– – – 5361
2017
Q2 		– Hold
0
– -$22K – 5084
2017
Q1 		– Hold
0
– – – 3842
2016
Q4 		– Hold
0
– – – 4106
2016
Q3 		– Hold
0
– – – 3937
2016
Q2 		– Hold
0
– – – 3503
2016
Q1 		– Hold
0
– – – 4171
2015
Q4 		– Hold
0
– – – 4221
2015
Q2 		– Hold
0
– – – 5181
2015
Q1 		– Hold
0
– – – 4114
2014
Q4 		– Hold
0
– – – 3455
2014
Q3 		– Hold
0
– – – 2979

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Group One Trading's TNXP Position: Q1 2026 in Review

Group One Trading reduced its Tonix Pharmaceuticals (TNXP) stake by 54% in Q1 2026, selling an estimated $13.9K and leaving 760 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6352.

Group One Trading first reported a position in TNXP in Q3 2025 and has held it in 3 quarters since. The position peaked at $25.9K in Q4 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Group One Trading held 760 shares of Tonix Pharmaceuticals worth $10.4K as of Q1 2026.
  • Group One Trading sold 900 Tonix Pharmaceuticals shares in Q1 2026, an estimated $13.9K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6352 holding.
  • Group One Trading first reported a position in Tonix Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Group One Trading's Tonix Pharmaceuticals position peaked at $25.9K in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.